Medicare Enrolled

Dr. Mohamed Khalil, M.D.

Sports Medicine (Neuromusculoskeletal Medicine) Physician · Webster, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
905 W MEDICAL CENTER BLVD STE 301, Webster, TX 77598
2817248334
In practice since 2012 (14 years)
NPI: 1124391198 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khalil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khalil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khalil

Dr. Mohamed Khalil is a sports medicine physician in Webster, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Khalil performed 10,215 Medicare services across 1,706 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khalil received a total of $15,077 from 80 pharmaceutical and/or device companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine (neuromusculoskeletal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khalil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 14% volume in TX $15,077 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,215
Medicare services
Top 14% in TX for sports medicine (neuromusculoskeletal medicine) physician
1,706
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~730 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,969 $0 $1
MRI contrast dye injection (gadoterate)
Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose.
1,290 $0 $1
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
1,087 $21 $87
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
858 $15 $62
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
690 $73 $294
Gadolinium MRI contrast injection
Administration of a gadolinium-based contrast agent to enhance magnetic resonance imaging. The dose is measured per milliliter of the agent injected.
610 $1 $5
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
498 $47 $193
Immune globulin infusion (Octagam)
This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form.
473 $21 $83
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
345 $1 $3
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
334 $1 $5
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
314 $68 $272
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
258 $44 $176
Destruction of peripheral nerve or branch 231 $270 $747
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
217 $94 $385
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
166 $212 $860
New patient office visit, complex (60-74 min) 161 $155 $664
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
156 $326 $1,332
Lidocaine HCl injection for IV infusion, 10 mg
Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion.
96 $0 $1
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
66 $202 $831
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
63 $8 $26
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $39 $171
Injection of carpal tunnel 42 $67 $251
MRI of brain with and without contrast
An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures.
41 $247 $1,006
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
37 $40 $186
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $133 $540
Auditory brainstem response test
A test that measures the brain's response to sound to determine hearing thresholds. The results are interpreted and reported by a medical professional.
23 $80 $343
Visual evoked potential test
A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli.
21 $48 $200
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
18 $162 $638
Facial nerve function study
A diagnostic test used to evaluate the health and function of the facial nerve.
16 $55 $214
Eye blink reflex nerve conduction test
A test that measures the electrical activity and conduction patterns of the nerves involved in the eye blink reflex.
16 $63 $249
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
14 $135 $529
MRI of head blood vessels without contrast
An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye.
13 $166 $679
MRI of lower spine with and without contrast
An MRI scan of the lower spinal canal performed both before and after the administration of contrast dye to enhance image detail.
13 $269 $1,010
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.5% high complexity
47.4% medium
23.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,077
Total received (2018-2024)
Avg $2,154/year across 7 years
Top 0% in TX for sports medicine (neuromusculoskeletal medicine) physician
80
Companies
748
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,641 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$437 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,378
2023
$2,940
2022
$2,677
2021
$1,688
2020
$1,196
2019
$1,435
2018
$1,764

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,258
UCB, Inc.
$951
ABBVIE INC.
$926
SK Life Science, Inc.
$775
Teva Pharmaceuticals USA, Inc.
$678
Grifols USA, LLC
$611
Alexion Pharmaceuticals, Inc.
$591
Lundbeck LLC
$571
GENZYME CORPORATION
$564
PFIZER INC.
$522
Allergan, Inc.
$474
Takeda Pharmaceuticals U.S.A., Inc.
$427
JAZZ PHARMACEUTICALS INC.
$426
Biogen, Inc.
$370
ARGENX US, INC.
$350
Amgen Inc.
$330
Eisai Inc.
$294
Neurocrine Biosciences, Inc.
$268
Biohaven Pharmaceutical Holding Company Ltd.
$268
ACADIA Pharmaceuticals Inc
$249
Kerecis Limited
$222
Biohaven Pharmaceuticals, Inc.
$194
Lilly USA, LLC
$191
W. L. Gore & Associates, Inc.
$182
Kyowa Kirin, Inc.
$163
Mallinckrodt Hospital Products Inc.
$151
AQUESTIVE THERAPEUTICS, INC.
$150
Genentech USA, Inc.
$140
Janssen Pharmaceuticals, Inc
$118
Assertio Therapeutics, Inc.
$112
AbbVie Inc.
$111
HOSPIRA, INC.
$108
CSL Behring
$104
Acorda Therapeutics, Inc
$100
Vertical Pharmaceuticals, LLC
$93
Supernus Pharmaceuticals, Inc.
$92
Sunovion Pharmaceuticals Inc.
$86
Octapharma USA, Inc.
$85
Abbott Laboratories
$84
US WorldMeds, LLC
$83
EISAI INC.
$83
Promius Pharma LLC
$83
Allergan Inc.
$82
ARBOR PHARMACEUTICALS, INC.
$82
GlaxoSmithKline, LLC.
$81
Corium, LLC
$81
Avion Pharmaceuticals
$77
Sumitomo Pharma America, Inc.
$71
Boston Scientific Corporation
$69
EMD Serono, Inc.
$54
Strongbridge US INC.
$52
ASSERTIO THERAPEUTICS, Inc.
$47
CATALYST PHARMACEUTICALS, INC.
$47
LivaNova USA, Inc.
$45
Ipsen Biopharmaceuticals, Inc
$43
Otsuka America Pharmaceutical, Inc.
$42
GE HEALTHCARE
$40
Arbor Pharmaceuticals, Inc.
$38
Banner Life Sciences, LLC
$33
Aucta Pharmaceuticals, Inc.
$32
Amarin Pharma Inc.
$31
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Azurity Pharmaceuticals, Inc.
$29
Musculoskeletal Transplant Foundation Inc.
$29
Currax Pharmaceuticals LLC
$28
BOSTON SCIENTIFIC CORPORATION
$27
Almatica Pharma LLC
$26
SpringWorks Therapeutics, Inc.
$25
Endo Pharmaceuticals Inc.
$24
Upsher-Smith Laboratories LLC
$23
UPSHER-SMITH LABORATORIES LLC
$19
Zyla Life Sciences
$19
Novo Nordisk Inc
$17
Amneal Pharmaceuticals LLC
$16
Horizon Pharma plc
$16
Scilex Pharmaceuticals Inc.
$14
SCILEX PHARMACEUTICALS INC.
$14
AstraZeneca Pharmaceuticals LP
$14
Avanir Pharmaceuticals, Inc.
$14
United Therapeutics Corporation
$13
Top 3 companies account for 20.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CAMBIA · CONTRAVE · COPAXONE · Cambia · Circulatory Support · DISEASE STATE · DIVIGEL · DUEXIS · Dhivy · Dysport · EMGALITY · EPIDIOLEX · ERBITUX · Edarbyclor · Esbriet · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · Kerecis Omega3 SurgiClose · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Motpoly XR · NAPRELAN · NASCOBAL · NONE · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · OSMOLEX ER · Ocrevus · PANZYGA · Proclaim Family of SCS IPGs · Prolia · QULIPTA · RADICAVA · REXULTI · RYTARY · Repatha · Rystiggo · SOLIRIS · SOMATULINE DEPOT · SPINRAZA · SPRIX · SYMPAZAN · Saxenda · Soliris · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · ULTOMIRIS · VERCISE · VIGADRONE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Vercise · Vimpat · XARELTO · XCOPRI · Xadago · Xembify · ZEMBRACE SYMTOUCH · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 0% for sports medicine (neuromusculoskeletal medicine) physician in TX.

Equivalent to $148 per 100 Medicare services performed
Looking for a sports medicine physician in Webster?
Compare sports medicine physicians in the Webster area by procedure volume, costs, and industry payment transparency.
Browse sports medicine physicians nearby

Geographic Context

Sports medicine physicians within 10 mi
3
Per 100K population
0.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khalil is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), with low-engagement industry engagement in the top 0% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khalil experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Khalil performed 1,969 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khalil receive payments from pharmaceutical companies?
Yes. Dr. Khalil received a total of $15,077 from 80 companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khalil's costs compare to other sports medicine physicians in Webster?
Dr. Khalil's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khalil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →